Skip to content

Meet us at COP31Read more

Kyowa Kirin Co Ltd Sustainability Reports

Kyowa Kirin Co., Ltd. is a Japan-based global specialty pharmaceutical company that applies cutting-edge biotechnology and fermentation technologies to discover, develop, and commercialize novel medicines. The company specializes in core therapeutic fields such as oncology, nephrology, immunology, and central nervous system diseases.

Sector: Manufacturing

Country: Japan

Exchange: Tokyo Stock Exchange

LEI: 529900TBXKVTQGYA3582

FIGI: BBG001S6B983

37 reports from 1999 to 2026